Biotech · Private company
Human Genome Sciences Inc., a GSK Company
Track this companyFree. Adds Human Genome Sciences Inc., a GSK Company to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Belimumab 10 mg/kg plus standard therapyPhase 3 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Standard therapyPhase 3 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- BelimumabPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Belimumab 10 mg/kg plus standard therapySystemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Standard therapySystemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)PHASE4 · COMPLETED · started Feb 19, 2013ClinicalTrials.gov NCT01632241 · fetched Nov 12, 2026
- Pediatric Lupus Trial of Belimumab Plus Background Standard TherapyPHASE2 · COMPLETED · started Sep 7, 2012ClinicalTrials.gov NCT01649765 · fetched Nov 12, 2026
- Efficacy and Safety of Belimumab in Patients With Active Lupus NephritisPHASE3 · COMPLETED · started Jul 12, 2012ClinicalTrials.gov NCT01639339 · fetched Nov 12, 2026
- A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02PHASE2 · COMPLETED · started May 4, 2005ClinicalTrials.gov NCT00583362 · fetched Nov 12, 2026